The Agitation In Alzheimer’s Screener For Caregivers (AASC™) Scale
The Agitation in Alzheimer’s Screener for Caregivers (AASC™) is a brief screening tool based on the International Psychogeriatric Association (IPA) consensus definition for agitation in cognitive disorders and was designed to assist caregivers in recognizing agitation associated with Alzheimer’s dementia (AAD). Please click on link below for a downloadable version of the AASC. The information on the website and from the questionnaire are not a substitute for professional/clinical judgement. The content is designed to provide educational information and not intended to define a standard of care of exclusive course of treatment. The AASC™ is a screening tool and is not a diagnostic tool.
Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
-
Monoamine Neurotransmitter Dysregulation in Major Depressive Disorder
Join us for a PsychU webinar with Drs. W. Clay Jackson and Christian Aurup as they discuss the potential relationship between the monoamine neurotransmitter systems in Major Depressive Disorder (MDD).